7 research outputs found
Evaluation of the symbol digit modalities test (SDMT) and MS neuropsychological screening questionnaire (MSNQ) in natalizumab-treated MS patients over 48 weeks
Brief cognitive tests to monitor cognitive impairment in patients with multiple sclerosis (MS) are needed